Mid West Hemotology Oncology Group Inc is categorized under Oncologists in Saint Louis, MO and active since 1981.
Mid West Hemotology Oncology Group Inc was established in 1981, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Susan Luedke at the company’s single location by writing to 6435 Chippewa St, Saint Louis, Missouri MO 63109 or by phoning (314) 353-1870. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Mid West Hemotology Oncology Group Inc |
| Contact Person: | Susan Luedke |
| Address: | 6435 Chippewa St, Saint Louis, Missouri 63109 |
| Phone Number: | (314) 353-1870 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Mid West Hemotology Oncology Group Inc was started in 1981 to provide professional Oncologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Susan Luedke for inquiries that concern Mid West Hemotology Oncology Group Inc by calling the company number (314) 353-1870, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid West Hemotology Oncology Group Inc can be found at the coordinates 38.593853,-90.299128 as well as the street address 6435 Chippewa St in Saint Louis, Missouri 63109.
For its online presence, you may visit Mid West Hemotology Oncology Group Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.